Your browser doesn't support javascript.
loading
Looking Back, Looking Forward at Halogen Bonding in Drug Discovery.
Mendez, Lois; Henriquez, Gabriela; Sirimulla, Suman; Narayan, Mahesh.
Afiliação
  • Mendez L; Department of Chemistry, The University of Texas at El Paso, El Paso, TX 79968, USA. lmendez9@miners.utep.edu.
  • Henriquez G; Environmental Science and Engineering Program, The University of Texas at El Paso, El Paso, TX 79968, USA. ghenriquez@miners.utep.edu.
  • Sirimulla S; School of Pharmacy, The University of Texas at El Paso, El Paso, TX 79968, USA. ssirimulla@utep.edu.
  • Narayan M; Department of Chemistry, The University of Texas at El Paso, El Paso, TX 79968, USA. mnarayan@utep.edu.
Molecules ; 22(9)2017 Aug 24.
Article em En | MEDLINE | ID: mdl-28837116
ABSTRACT
Halogen bonding has emerged at the forefront of advances in improving ligand receptor interactions. In particular the newfound ability of this extant non-covalent-bonding phenomena has revolutionized computational approaches to drug discovery while simultaneously reenergizing synthetic approaches to the field. Here we survey, via examples of classical applications involving halogen atoms in pharmaceutical compounds and their biological hosts, the unique advantages that halogen atoms offer as both Lewis acids and Lewis bases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Descoberta de Drogas / Halogênios Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Descoberta de Drogas / Halogênios Idioma: En Ano de publicação: 2017 Tipo de documento: Article